WELLS FARGO & COMPANY/MN - ITERUM THERAPEUTICS PLC ownership

ITERUM THERAPEUTICS PLC's ticker is and the CUSIP is G6333L200. A total of 13 filers reported holding ITERUM THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of ITERUM THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$1,029
+1030.8%
1,285
+1411.8%
0.00%
Q2 2023$91
+7.1%
850.0%0.00%
Q1 2023$85
+19.7%
850.0%0.00%
Q4 2022$7185
-72.1%
0.00%
Q3 2022$03050.00%
Other shareholders
ITERUM THERAPEUTICS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 75,000$1,125,0000.92%
New Leaf Venture Partners, L.L.C. 97,084$103,8800.09%
Apollon Wealth Management, LLC 200,000$214,0000.01%
UBS Group AG 48$510.00%
NewEdge Advisors, LLC 100$1070.00%
OSAIC HOLDINGS, INC. 12$120.00%
WELLS FARGO & COMPANY/MN 85$910.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
HM PAYSON & CO 3$40.00%
MORGAN STANLEY 13,950$14,9270.00%
View complete list of ITERUM THERAPEUTICS PLC shareholders